Anteris Technologies Global (NASDAQ:AVR – Get Free Report) and Covalon Technologies (OTCMKTS:CVALF – Get Free Report) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, valuation, risk, analyst recommendations, earnings, dividends and profitability.
Analyst Ratings
This is a breakdown of current ratings and target prices for Anteris Technologies Global and Covalon Technologies, as provided by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Anteris Technologies Global | 1 | 0 | 3 | 0 | 2.50 |
| Covalon Technologies | 0 | 0 | 0 | 0 | 0.00 |
Anteris Technologies Global currently has a consensus price target of $15.33, suggesting a potential upside of 147.31%. Given Anteris Technologies Global’s stronger consensus rating and higher possible upside, analysts clearly believe Anteris Technologies Global is more favorable than Covalon Technologies.
Valuation and Earnings
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Anteris Technologies Global | $1.91 million | 315.62 | -$94.14 million | ($2.56) | -2.42 |
| Covalon Technologies | $23.43 million | 1.70 | $1.47 million | $0.02 | 72.00 |
Covalon Technologies has higher revenue and earnings than Anteris Technologies Global. Anteris Technologies Global is trading at a lower price-to-earnings ratio than Covalon Technologies, indicating that it is currently the more affordable of the two stocks.
Profitability
This table compares Anteris Technologies Global and Covalon Technologies’ net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Anteris Technologies Global | -4,921.27% | -536.04% | -267.57% |
| Covalon Technologies | 3.08% | 3.31% | 2.80% |
Risk & Volatility
Anteris Technologies Global has a beta of 1.58, meaning that its share price is 58% more volatile than the S&P 500. Comparatively, Covalon Technologies has a beta of 0.56, meaning that its share price is 44% less volatile than the S&P 500.
Summary
Covalon Technologies beats Anteris Technologies Global on 7 of the 12 factors compared between the two stocks.
About Anteris Technologies Global
Anteris Technologies Global Corp. engages in the development and commercialization of medical devices for heart diseases. The company was founded in 1999 and is headquartered in Eagan, MN.
About Covalon Technologies
Covalon Technologies Ltd. engages in the research, development, manufacturing, and marketing of medical products in infection management, advanced wound care, and surgical procedure areas in the United States, Canada, the Middle East, Asia, Latin America, and internationally. The company’s platform technologies comprise collagen matrix platform that is used to manufacture a family of products to treat chronic and infected wounds, including diabetic ulcers, pressure ulcers, venous ulcers, donor and graft sites, traumatic wounds healing by secondary intention, dehisced surgical wounds, and first and second degree burns; and antimicrobial silicone adhesive platform, which is used for family of pre and post-surgical, and vascular access products that are designed to kill bacteria or yeast that comes into contact with the antimicrobial silicone providing broad-spectrum antimicrobial activity. It also offers medical coating platform, a process that utilizes photo-polymerization to create active grafting sites where new polymer chains are initiated and propagated from the surface of an existing medical device. In addition, the company provides wound care dressings; surgical and peri-operative; and infection management products. It offers its products under the Covalon brand name through third-party distribution networks and company’s direct sales force. The company serves hospitals, wound care centers, burn centers, extended/alternate care and acute care facilities, home health care agencies, and physicians’ offices. Covalon Technologies Ltd. is headquartered in Mississauga, Canada.
Receive News & Ratings for Anteris Technologies Global Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Anteris Technologies Global and related companies with MarketBeat.com's FREE daily email newsletter.
